Mahdi Mahdipour

Dr. Mahdi Mahdipour

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SAShahin Ahmadian
Shahin Ahmadian
NJNegin Jafari
Negin Jafari
Amin TamadonAmin Tamadon
Amin Tamadon
AGAlireza Ghaffarzadeh
Alireza Ghaffarzadeh
RRReza Rahbarghazi
Reza Rahbarghazi
MMMahdi Mahdipour
Mahdi Mahdipour
Extracellular vesicles (EVs) have been considered promising tools in regenerative medicine. However, the nanoscale properties of EVs make them sensitive to environmental conditions. Optimal storage protocols are crucial for maintaining EV structural, molecular, and functional integrity. This systematic review aimed to gather evidence on the effects of various storage protocols on EV characteristics and integrity. A comprehensive search was conducted for original studies investigating the impacts of storage temperature, freezing techniques, freeze-thaw cycles, and stabilizing strategies on EV concentration, size distribution, morphology, cargo content, and bioactivity. Results from 50 included studies were analyzed. Data indicated that rapid freezing procedures and constant subzero temperatures (optimally − 80 °C) resulted in appropriate EV quantity and cargo preservation. Subjecting EVs to multiple freeze-thaw cycles decreased particle concentrations, RNA content, impaired bioactivity, and increased EV size and aggregation. Electron microscopy revealed vesicle enlargement, and fusion, along with membrane deformation after being exposed to substandard storage protocols. The addition of stabilizers like trehalose helped EVs to maintain integrity. Of note, storage in native biofluids offered improved stability over purified EVs in buffers. Data emphasize the critical need for precise storage protocols for EVs to ensure reproducible research outcomes and clinical applications. Further studies using reliable methods are necessary to create specific guidelines for improving the stability of EVs in various applications.

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RRReza Rikhtegar
Reza Rikhtegar
MPMasoud Pezeshkian
Masoud Pezeshkian
SDSanam Dolati
Sanam Dolati
NSNaser Safaie
Naser Safaie
ARAbbas Afrasiabi Rad
Abbas Afrasiabi Rad
MYMehdi Yousefi
Mehdi Yousefi
Heart Diseases are serious and global public health concern. In spite of remarkable therapeutic developments, the prediction of patients with Heart Failure (HF) is weak, and present therapeutic attitudes do not report the fundamental problem of the cardiac tissue loss. Innovative therapies are required to reduce mortality and limit or abolish the necessity for cardiac transplantation. Stem cell-based therapies applied to the treatment of heart disease is according to the understanding that natural self-renewing procedures are inherent to the myocardium, nonetheless may not be adequate to recover the infarcted heart muscle. Following the first account of cell therapy in heart diseases, examination has kept up to rapidity; besides, several animals and human clinical trials have been conducted to preserve the capacity of numerous stem cell population in advance cardiac function and decrease infarct size. The purpose of this study was to censoriously evaluate the works performed regarding the usage of four major subgroups of stem cells, including induced Pluripotent Stem Cells (iPSC), Embryonic Stem Cells (ESCs), Cardiac Stem Cells (CDC), and Skeletal Myoblasts, in heart diseases, at the preclinical and clinical studies. Moreover, it is aimed to argue the existing disagreements, unsolved problems, and prospect directions.

5 August 2020 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
SAShahin Ahmadian
Shahin Ahmadian
SSSepideh Sheshpari
Sepideh Sheshpari
MPMohammad Pazhang
Mohammad Pazhang
ABAlberto Miranda Bedate
Alberto Miranda Bedate
RBRahim Beheshti
Rahim Beheshti
MMMahdi Mahdipour
Mahdi Mahdipour
Premature Ovarian Insufficiency (POI) is viewed as a type of infertility in which the menopausal status occurs before the physiological age. Several therapeutic strategies have been introduced in clinic for POI treatment, although the outputs are not fully convincing. Platelet-rich plasma (PRP) is a unique blood product widely applied in regenerative medicine, which is based on the releasing of the growth factors present in platelets α-granules. In the current investigation, we examined the effectiveness of PRP as a therapeutic alternative for POI animals. POI in Wistar albino rats was induced by daily intraperitoneal (IP) administration of gonadotoxic chemical agent, 4-vinylcyclohexene dioxide (VCD) (160 mg/ kg) for 15 consecutive days. After POI induction, the PRP solution was directly injected intra-ovarian in two concentrations via a surgical intervention. Every two weeks post-injection, pathological changes were monitored in the ovaries using Hematoxylin-Eosin staining method, until eight weeks. Follicle Stimulating Hormone (FSH) content in serum was measured, together with the expression of the angiogenic-related transcripts ANGPT2 and KDR by real-time qPCR. Furthermore the fertility status of the treated rats was evaluated by mating trials. Histopathological examination revealed successful POI induction via the depletion of morphologically normal follicles in rats following VCD treatment compared to the control rats. The injection of PRP at two concentrations reduced the number and extent of the follicular atresia and inflammatory responses (p < 0.05). The expression of both ANGPT2 and KDR transcripts were significantly increased in POI rats due to enhanced inflammation, while these values were modulated after PRP administration (p < 0.05) compared to POI rats. FSH showed a decreased trend in concentration eight weeks after PRP treatment, but not statistically significant (p > 0.05). Nevertheless, a clear improvement in litter counts was found in POI rats receiving PRP compared to the non-treated POI group, being able to consider PRP as a facile, quick, accessible, safe and relatively cheap alternative therapeutic strategy to revert POI-related pathologies.

1 June 2021 in Life Sciences
Verified
Journal Article
Closed access
HMHalimeh Mobarak
Halimeh Mobarak
MHMohammad Heidarpour
Mohammad Heidarpour
RRReza Rahbarghazi
Reza Rahbarghazi
MNMohammad Nouri
Mohammad Nouri
MMMahdi Mahdipour
Mahdi Mahdipour

10 December 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
EDEhsan Dezhakam
Ehsan Dezhakam
BKBalal Khalilzadeh
Balal Khalilzadeh
MMMahdi Mahdipour
Mahdi Mahdipour
IIIbrahim Isildak
Ibrahim Isildak
HYHadi Yousefi
Hadi Yousefi
RRReza Rahbarghazi
Reza Rahbarghazi

29 November 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SSSepideh Sheshpari
Sepideh Sheshpari
MSMahnaz Shahnazi
Mahnaz Shahnazi
HMHalimeh Mobarak
Halimeh Mobarak
SAShahin Ahmadian
Shahin Ahmadian
ABAlberto Miranda Bedate
Alberto Miranda Bedate
MMMahdi Mahdipour
Mahdi Mahdipour
The aim of this systematic review study is to summarize the current knowledge of ovarian tissue transplantation and provide insight on ovarian function, fertility and reproductive outcome following ovarian tissue transplantation. Relevant studies were identified by searching through PubMed, Cochrane Library, Embase, ProQuest, and Scopus databases until August 2018. Ovarian function by examination of the hormonal level was evaluated, together with follicular growth, the return of menstrual cycle and assessment of reproductive consequences: pregnancy, miscarriage rates and live birth after transplantation. Studies including female patients aged between 22 and 49 years that were subjected to ovarian tissue transplantation were considered. A total of 1185 studies were identified in the primary search. Titles and abstracts were screened for assessment of the inclusion criteria. Finally, twenty-five articles met the criteria and were included in this study. In general, 70% of patients that underwent ovarian tissue transplantation had ovarian and endocrine function restoration as well as follicular growth. Pregnancy was reported with 52% of the patients. The available evidence suggests that ovarian tissue transplantation is a useful and an applied approach to restore hormonal function, endocrine balance and eventually fertility outcomes in patients that are predisposed to lose their fertility, diagnosed with premature ovarian failure (POF), as well as women undergoing cancer treatments. Identification of the techniques with the lowest invasions for follicular and oocyte development after ovarian tissue transplantation aiming to reduce probable adverse effects after treatment is indispensable.